PEOPLE - Changes at Medical Ventures:
This article was originally published in Clinica
Cardiovascular device developer Medical Ventures (Richmond, British Columbia) has announced that Douglas Janzen will join the board of directors. Mr Janzen has senior financial experience in the pharma and biotech industries. Paul Geyer, president and CEO, commented that Mr Janzen's experience would aid the company's growth as it acquires approvals of its core catheter and tissue products.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.